<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26869">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02070315</url>
  </required_header>
  <id_info>
    <org_study_id>012-011</org_study_id>
    <nct_id>NCT02070315</nct_id>
  </id_info>
  <brief_title>Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM</brief_title>
  <official_title>Quantitative Evaluation of Liver and Kidney Disease With Liver and Kidney Elastography Measurements in Liver Transplant Recipients Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor Research Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Liver biopsy for the assessment of fibrosis has multiple limitations.  Liver ShearWaveTM
      Elastography may provide a non-invasive, fast, and reproducible alternative for the
      quantitative assessment of liver fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To obtain a quantitative evaluation of the progression of liver disease, using ShearWaveTM
      Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine.

      To compare the glomerular filtration rate and the quantitative evaluation of the progression
      of renal disease, using ShearWaveTM Elastography measurements obtained with the Supersonic
      Imagine Aixplorer ultrasound machine in post-liver transplantation patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Shearwave Elastography Ultrasound</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients will have a scan performed at thier regularly scheduled clinic visits.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Liver Disease</condition>
  <condition>Renal Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        participants will be from Liver Consultants of Texas patient population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and Females over the age of 18

          -  Patients of LCOT Dallas office, with chronic liver disease

          -  Liver Transplant Recipients

        Exclusion Criteria:

          -  Any person unable to provide an informed consent

          -  Any female who is pregnant or thinks she might be pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Trotter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor Health Care System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristy Sanders, RN,BSN</last_name>
    <phone>214-820-1737</phone>
    <email>Kristy.Sanders@Baylorhealth.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jordyn Talley</last_name>
    <phone>214-818-7815</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristy Sanders, RN,BSN</last_name>
      <phone>214-820-1737</phone>
      <email>Kristy.Sanders@Baylorhealth.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 21, 2014</lastchanged_date>
  <firstreceived_date>January 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>renal failure</keyword>
  <keyword>liver failure</keyword>
  <keyword>post liver transplant</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
